Subclinical hypothyroidism and metabolic syndrome: reasons for drug intervention

Subclinical hypothyroidism and metabolic syndrome: reasons for drug intervention

The high prevalence of metabolic syndrome (MS) and subclinical hypothyroidism (SHypo) creates danger of integral cardio-metabolic risk (CMR). A concept is being developed to increase thyroid-stimulating hormone (TSH) levels as a component of MS with the key role of insulin resistance (IR). To identi...

Full description

Bibliographic Details
Main Authors: Lyudmila A. Ruyatkina, Dmitriy S. Ruyatkin
Format: Article
Language:English
Published: Endocrinology Research Centre 2020-06-01
Series:Ожирение и метаболизм
Subjects:
subclinical hypothyroidism
metabolic syndrome
thyroid-stimulating hormone
insulin resistance
cardio-metabolic risk
metformin
Online Access:https://omet-endojournals.ru/omet/article/viewFile/12282/9562

Internet

https://omet-endojournals.ru/omet/article/viewFile/12282/9562

Similar Items